Source Post

Adam May on investing in biotech $NKTR $ABVX

This episode features a discussion with Adam May, a physician and prominent figure in Biotech FinTwit. The conversation delves into his background, his journey into investing in small to mid-cap biotech companies, and the inherent risks and potential rewards within the sector. The host also highlights a sponsor, Trada, a platform for buy-side interviews about stocks.

Linked Mentions

Tickers discussed in this post

ABVXNeutralLow ConvictionResearch Only

Abivax SA (ABVX) is mentioned in the post title as a topic of discussion.

NKTRNeutralLow ConvictionResearch Only

Nektar Therapeutics (NKTR) is mentioned in the post title as a topic of discussion.

Linked Signals

Tracked calls opened from this post

No linked signals were opened directly from this post.